Literature DB >> 29294466

In brief: Pembrolizumab (Keytruda) for cancers with biomarkers.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29294466

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  1 in total

Review 1.  Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy.

Authors:  Shadma Fatima; Yafeng Ma; Azadeh Safrachi; Sana Haider; Kevin J Spring; Fatemeh Vafaee; Kieran F Scott; Tara L Roberts; Therese M Becker; Paul de Souza
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.